Does GEMCITABINE Cause Bladder cancer recurrent? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Bladder cancer recurrent have been filed in association with GEMCITABINE (Gemcitabine). This represents 0.1% of all adverse event reports for GEMCITABINE.
15
Reports of Bladder cancer recurrent with GEMCITABINE
0.1%
of all GEMCITABINE reports
1
Deaths
2
Hospitalizations
How Dangerous Is Bladder cancer recurrent From GEMCITABINE?
Of the 15 reports, 1 (6.7%) resulted in death, 2 (13.3%) required hospitalization.
Is Bladder cancer recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEMCITABINE. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does GEMCITABINE Cause?
Off label use (3,319)
Disease progression (3,123)
Thrombocytopenia (2,320)
Drug ineffective (2,003)
Malignant neoplasm progression (1,962)
Neutropenia (1,892)
Anaemia (1,745)
Pyrexia (1,511)
Nausea (1,336)
Myelosuppression (1,197)
What Other Drugs Cause Bladder cancer recurrent?
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (231)
PIOGLITAZONE (130)
RANITIDINE (66)
BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (28)
MITOMYCIN (20)
PEMBROLIZUMAB (20)
ADALIMUMAB (19)
GEMCITABINE\GEMCITABINE (19)
METHOTREXATE (16)
INTERFERON ALFA-2B (14)
Which GEMCITABINE Alternatives Have Lower Bladder cancer recurrent Risk?
GEMCITABINE vs GEMCITABINE\GEMCITABINE
GEMCITABINE vs GEMFIBROZIL
GEMCITABINE vs GEMTUZUMAB OZOGAMICIN
GEMCITABINE vs GEMZAR
GEMCITABINE vs GENTAMICIN